SightGlass Slows Myopia Progression

A trial that has been in process for two years has found that SightGlass Vision’s Diffusion Optics Technology slowed progression of myopia when compared to a group that did not wear the lenses.

It showed 85% of children who wore the spectacle lenses showed less than one diopter of myopia progression after being worn for two years.

Joe Rappon, chief medical officer for SightGlass Vision, said: ‘Applying our Diffusion Optics

Technology to spectacle lenses makes myopia management straightforward to integrate within eye care practices and easy to become part of children’s everyday lives.’